Welcome to Stanton Glantz blog
Commentary on tobacco, cannabis and public health
Latest from the Blog
Over 100 organizations and many individual scientists (including me) have written HHS Secretary Javier Becerra recommending specific actions that HHS and its agencies can take to better integrate climate change into developing research and policy. Here is a summary of the recommendations: Climate Change, Health and Equity at the Department of Health and Human ServicesContinue reading “Over 100 organizations urge HHS to integrate effects of global warming into health policies”
As the April 29 deadline for the Biden Administration to respond to a lawsuit brought by the African American Tobacco Control Leadership Council and Action on Smoking and Health approaches, the results of a large national survey from Canada show that banning the sale of menthol cigarettes was followed by a huge increase in smokingContinue reading “Banning menthol leads to big drop in smoking in Canada: Implications for USA”
There are two separate decisions that the FDA makes about new products: (1) whether to authorize the sale of the product, and, if they allow sale of a product, (2) whether to allow a company to make reduced exposure or reduced risk claims about the product. To further confuse the situation, the separate decisions aboutContinue reading “Why FDA’s reduced exposure marketing order for IQOS is not a reliable global model”
Get new content delivered directly to your inbox.